Parmax Pharma Ltd
BSE: 540359
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 8.22+90.0% | 4.33+70.9% | 2.53+30.3% | 1.94-59.8% | 4.83-23.2% | 6.28-32.3% | 9.28 |
| Other Income | 2.08+28776.4% | 0.01+2.9% | 0.01+4.5% | 0.01+106.9% | -0.10-851.5% | 0.01-88.9% | 0.12 |
| Total Income | 10.30+137.7% | 4.33+70.7% | 2.54+30.2% | 1.95-58.8% | 4.73-24.9% | 6.30-33.0% | 9.39 |
| EXPENSES | |||||||
| Expenditure | 8.10+59.9% | 5.06+9.7% | 4.62+70.1% | 2.71-50.2% | 5.45-18.5% | 6.69-30.4% | 9.61 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00+100.0% | -0.30 | — | — |
| PROFIT | |||||||
| PBT | 2.20+400.5% | -0.73+64.8% | -2.08-171.9% | -0.76+57.4% | -1.80-354.7% | -0.40-82.0% | -0.22 |
| Net Profit | 2.20+400.5% | -0.73+64.8% | -2.08-171.9% | -0.76+48.9% | -1.49-278.5% | -0.40-82.0% | -0.22 |
| KEY METRICS | |||||||
| OPM % | 10.08%+14.64pp | -4.56%+58.25pp | -62.81%-49.94pp | -12.87%+21.06pp | -33.93%-19.24pp | -14.69%-5.36pp | -9.33% |
| NPM % | 21.35%+38.24pp | -16.89%+65.01pp | -81.90%-42.67pp | -39.23%-7.61pp | -31.62%-25.35pp | -6.27%-3.96pp | -2.31% |
| EPS | 5.88+200.0% | 1.96-64.7% | 5.56+172.5% | 2.04-49.0% | 4.00+481.0% | -1.05-81.0% | -0.58 |
Corporate Events
Board Meeting
To consider and approve unaudited financial results for the …
BSE Filing ↗Board Meeting
The Annual General Meeting will be held to consider and adop…
BSE Filing ↗Board Meeting
The Thirty Second (32nd) Annual General Meeting (AGM) of Mem…
BSE Filing ↗Board Meeting
The Board of Directors approved the allotment of 31,37,586 f…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Extraordinary General Meeting (EGM) of the Company is sc…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve fund …
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Reschedule of Board Meeting, Approve and consider unaudited …
BSE Filing ↗Board Meeting
Consider and approve un-audited standalone financial results
BSE Filing ↗